Xiaochen Li
Papers
1
Total Citations
1
H-Index
1
About
Xiaochen Li is a leading urologic oncologist whose research focuses on improving surgical and prognostic outcomes in bladder cancer, particularly through the lens of robotic-assisted radical cystectomy. Dr. Li’s major contributions center on refining staging accuracy and treatment stratification for muscle-invasive bladder cancer (MIBC). In a pivotal 2025 study, Li and colleagues identified key clinical predictors of pathologic disease upstaging at radical cystectomy, demonstrating how staging inaccuracies can lead to either undertreatment or overtreatment. By stratifying patients based on neoadjuvant chemotherapy (NAC) receipt, this work provides critical guidance for personalizing surgical and systemic therapy decisions. Although a relatively recent publication, this study has already garnered attention for its direct clinical implications, earning its first citation and establishing a foundation for future risk-adapted protocols. Dr. Li’s research bridges the gap between robotic surgical technique and evidence-based oncologic management, helping to define which patients benefit most from aggressive local therapy versus systemic approaches. Through this work, Li is shaping the next generation of precision surgery in bladder cancer care.
Research Focus
Key Achievements
Top Papers
- 1